MACOM Technology vs Vir Biotechnology Inc. Common Stock — how do they compare? MACOM Technology trades at $287.95 (market cap $23.58B), while Vir Biotechnology Inc. Common Stock trades at $10.2 (market cap $1.80B). The key difference: MACOM Technology is far larger — about 13.1× Vir Biotechnology Inc. Common Stock's market cap, and Vir Biotechnology Inc. Common Stock is trading nearer its 52-week high, MACOM Technology nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold MACOM Technology for 8 Days and Vir Biotechnology Inc. Common Stock for 0 Days on average.
| MTSI | VIR | |
|---|---|---|
Market Cap | $23.58B | $1.80B |
Volume | 2,186,339 | 1,782,836 |
Sector | Technology | Health |
52-Week High | $409.68 | $11.78 |
52-Week Low | $135.91 | $5.12 |
Typical Hold Time | 8 Days | 0 Days |
Enterprise Value | $23.29B | $1.36B |
Signals from Pluang's Aura AI — not financial advice
MACOM Technology Solutions (MTSI) trades at $308.75, up 0.78% with strong momentum driven by AI semiconductor demand. The stock shows bullish technical signals with recent earnings beats and analyst consensus pointing to 35% upside potential. Revenue growth accelerated from $967M in 2025 to $1.2B in 2026 while achieving profitability turnaround from -$54M to $241M net income. Recent product launches in optical connectivity and institutional accumulation support the positive momentum.
Outlook remains favorable with semiconductor industry tailwinds and AI-driven demand, though elevated valuation multiples (P/E 98.33) and competitive pressures present risks. The consensus price target of $415.71 suggests significant upside if execution continues, but investors should monitor margin sustainability and market volatility.
No Aura AI signal available yet.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
MACOM develops analog, radio frequency, microwave, and optical semiconductors. Its components are used in telecommunications, data centers, industrial systems, aerospace, and defense applications.
Read more on MTSI →Vir Biotechnology, Inc. is a US clinical-stage biopharmaceutical company that develops monoclonal antibody-based medicines to treat and prevent serious infectious diseases.
Read more on VIR →